Voloridge Investment Management
NVCR icon

Voloridge Investment Management’s NovoCure NVCR Stock Holding History

Voloridge Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-407,204
Closed -$5.27M – 1194
2025
Q4 		$5.27M Sell
407,204
-224,340
-36% -$2.88M 0.02% 752
2025
Q3 		$8.16M Sell
631,544
-115,391
-15% -$1.54M 0.03% 606
2025
Q2 		$13.3M Buy
746,935
+20,969
+3% +$365K 0.05% 455
2025
Q1 		$12.9M Sell
725,966
-144,189
-17% -$3.27M 0.05% 483
2024
Q4 		$25.9M Sell
870,155
-158,270
-15% -$3.35M 0.09% 281
2024
Q3 		$16.1M Sell
1,028,425
-76,235
-7% -$1.38M 0.06% 438
2024
Q2 		$18.9M Buy
1,104,660
+46,437
+4% +$817K 0.07% 385
2024
Q1 		$16.5M Sell
1,058,223
-368,501
-26% -$5.42M 0.06% 380
2023
Q4 		$21.3M Sell
1,426,724
-279,864
-16% -$3.75M 0.08% 303
2023
Q3 		$27.6M Buy
1,706,588
+1,484,381
+668% +$42.8M 0.14% 210
2023
Q2 		$9.22M Buy
222,207
+211,389
+1,954% +$13.1M 0.04% 477
2023
Q1 		$651K Buy
+10,818
New +$864K ﹤0.01% 1188
2022
Q3 		– Sell
-62,818
Closed -$4.37M – 1560
2022
Q2 		$4.37M Buy
62,818
+21,780
+53% +$1.64M 0.02% 724
2022
Q1 		$3.4M Sell
41,038
-5,480
-12% -$404K 0.02% 780
2021
Q4 		$3.49M Buy
+46,518
New +$4.67M 0.02% 851
2021
Q3 		– Sell
-24,599
Closed -$5.46M – 1796
2021
Q2 		$5.46M Sell
24,599
-209,135
-89% -$40.7M 0.04% 610
2021
Q1 		$30.9M Buy
233,734
+56,851
+32% +$8.99M 0.23% 114
2020
Q4 		$30.6M Buy
176,883
+95,606
+118% +$13.1M 0.26% 83
2020
Q3 		$9.05M Buy
81,277
+37,727
+87% +$3.02M 0.08% 282
2020
Q2 		$2.58M Buy
+43,550
New +$2.86M 0.03% 532
2019
Q4 		– Sell
-40,173
Closed -$3M – 1276
2019
Q3 		$3M Buy
40,173
+10,974
+38% +$878K 0.05% 352
2019
Q2 		$1.85M Sell
29,199
-29,187
-50% -$1.48M 0.05% 337
2019
Q1 		$2.81M Buy
+58,386
New +$2.81M 0.08% 228
2018
Q3 		– Sell
-98,290
Closed -$3.08M – 419
2018
Q2 		$3.08M Buy
+98,290
New +$2.73M 0.08% 228

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Voloridge Investment Management's NVCR Position: Q1 2026 in Review

Voloridge Investment Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 407,204 shares — an estimated $5.27M sold.

Voloridge Investment Management first reported a position in NVCR in Q2 2018 and held it in 24 quarters. The position peaked at $30.9M in Q1 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Voloridge Investment Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 407,204 NovoCure shares in Q1 2026, an estimated $5.27M.
  • Voloridge Investment Management first reported a position in NovoCure in Q2 2018 and held it in 24 quarters.
  • Voloridge Investment Management's NovoCure position peaked at $30.9M in Q1 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.